Pharmadons

Pharmadons has been active since 2006 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €98,180 and a net result of -€9,746. Equity is growing by about 24% per year across the filed financial years. Its solvency ranks better than 27% of 12,578 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.5% (low).